Study Evaluating the Safety, Tolerability and Pharmacokinetics of AMG 655 in Subjects with Advanced Tumors

Sponsor ID

20050171

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

conatumumab

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.